1.
Rev Cardiovasc Med
; 19(S1): S47-S50, 2018.
Article
in English
| MEDLINE
| ID: mdl-30207557
Subject(s)
Anticholesteremic Agents/supply & distribution , Anticholesteremic Agents/therapeutic use , Cholesterol, LDL/blood , Dyslipidemias/drug therapy , Health Services Accessibility , PCSK9 Inhibitors , Serine Proteinase Inhibitors/supply & distribution , Serine Proteinase Inhibitors/therapeutic use , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Biomarkers/blood , Clinical Decision-Making , Dyslipidemias/blood , Dyslipidemias/diagnosis , Dyslipidemias/enzymology , Evidence-Based Medicine , Humans , Patient Selection , Proprotein Convertase 9/metabolism , Treatment Outcome
2.
COPD
; 9(6): 581-2, 2012 Dec.
Article
in English
| MEDLINE
| ID: mdl-23244168